Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

Feb 14, 2018, 13:57 ET Inaugural Rare Disease Patient Advocacy Guidelines Published

Susan Stein, MPH, CEO and Founder of the award-winning Connexion Healthcare, has announced the open-access publication of rare disease patient...


Feb 14, 2018, 12:15 ET Two Day Method Development and Validation for Assays Supporting Testing of Biologics Seminar (Orlando, FL, United States - March 22-23, 2018)

The "Method Development and Validation for Assays Supporting Testing of Biologics" conference has been added to ResearchAndMarkets.com's...


Feb 14, 2018, 09:25 ET RegeneRx Receives Canadian Patent for Treating Neurological Injury and Damage

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue...


Feb 14, 2018, 09:00 ET Lumenis presenta il tema "Acustica e Calore" e la tecnologia PicoFractional™ alla riunione annuale dell'American Academy of Dermatology (AAD)

Lumenis Ltd., la maggiore azienda al mondo di dispositivi medici dipendenti da una fonte di energia per applicazioni estetiche, chirurgiche e...


Feb 14, 2018, 09:00 ET Lumenis zeigt Erfahrung mit Akustik und Hitze und stellt auf der Jahresversammlung der Amerikanischen Akademie der Dermatologie (AAD) seine PicoFractional™-Technologie vor

Lumenis Ltd., das weltweit größte energiebasierte Medizinproduktunternehmen für ästhetische, chirurgische und augenheilkundliche Anwendungen, ist...


Feb 14, 2018, 09:00 ET Lumenis présente l'expérience Acoustics & Heat et dévoile la technologie Pico Fractional™ lors de la réunion annuelle de l'American Academy of Dermatology (AAD)

Lumenis Ltd., la plus grande société au monde d'appareils médicaux basés sur l'énergie pour des applications esthétiques, chirurgicales et...


Feb 14, 2018, 08:30 ET In Vivo Toxicology Market Worth 6.14 Billion USD by 2022

According to a new market research "In Vivo Toxicology Market by Product (Instruments, Consumables (Animal models, Reagents & Kits)),...


Feb 14, 2018, 08:30 ET PharmaMar Licenses Fully Synthetic Marine-derived Payloads to Seattle Genetics for Use in Drug Conjugates

PharmaMar (MCE: PHM) has announced today the signing of an exclusive licensing agreement with Seattle Genetics Inc. (SGEN: NASDAQ GS) under...


Feb 14, 2018, 08:30 ET A Fully Automation Solution for DNA Isolation From 10 ml of Whole Blood Providing More Throughput Than Current Systems

Omega Bio-tek, a biotech company based in Norcross, Georgia, announces the launch of its new product, Mag-Bind® Blood DNA HV Kit, which can extract...


Feb 14, 2018, 08:30 ET China Biologic to Build New Collection Station in Hainan Province

China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based...


Feb 14, 2018, 08:00 ET China Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2018 Financial Results

Earnings Call Scheduled for 8:00 a.m. ET on February 27, 2018 China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it...


Feb 14, 2018, 08:00 ET DURECT Announces Resubmission of REMOXY® ER New Drug Application by its licensee, Pain Therapeutics

DURECT Corporation (Nasdaq: DRRX) today announced that its licensee, Pain Therapeutics (Nasdaq: PTIE), reported yesterday that it has resubmitted...


Feb 14, 2018, 08:00 ET Blueprint Medicines to Report Fourth Quarter and Full Year 2017 Financial Results on Wednesday, February 21, 2018

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically...


Feb 14, 2018, 07:00 ET The Bruker MALDI Biotyper Solution Receives AOAC International Approvals for Two Official Methods of Analysis (OMA) in Food Microbiology

Bruker is pleased to announce that AOAC International has approved the MALDI Biotyper solution for two new Official Methods of Analysis (OMA) for...


Feb 14, 2018, 07:00 ET Alkermes plc Reports Financial Results for the Year Ended Dec. 31, 2017 and Provides Financial Expectations for 2018

Alkermes plc (Nasdaq: ALKS) today reported financial results for the twelve months ended Dec. 31, 2017 and provided financial expectations for...


Feb 14, 2018, 07:00 ET Galmed Announces ARRIVE Study Data

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmedˮ or the "Company"), a clinical-stage biopharmaceutical company focused on the development of...


Feb 14, 2018, 07:00 ET PDL BioPharma to Present at Two Upcoming Investor Conferences

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, PDL's chief executive officer, will present at the following two...


Feb 14, 2018, 06:45 ET Biotech Stocks' Research Reports Released on OvaScience, Pacific Biosciences of California, Neuralstem, and Pieris Pharma

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on OVAS, PACB, CUR, and...


Feb 14, 2018, 06:40 ET What's Happening With These Generic Drugs Stocks? -- Neos Therapeutics, Pacira Pharma, pSivida, and Tetraphase Pharma

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on NEOS, PCRX, PSDV, and...


Feb 14, 2018, 06:00 ET United Therapeutics Corporation To Report Fourth Quarter And Annual 2017 Financial Results Before The Market Opens On Wednesday, February 21, 2018

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its fourth quarter and annual 2017 financial results before the...